GSK pays ABL Bio $49.5M upfront for blood-brain barrier platform access, with potential $2.67B in milestone payments. Deal ...

Gene editing pioneer David Liu was awarded one of three Breakthrough Prizes in Life Sciences for his invention of base and ...

The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have ...

On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...

The Cambridge, MA-based biotech is letting go of about 70 employees, a spokesperson confirmed to Endpoints News on Friday ...

Camilla Sylvest has moved on from Novo Nordisk after 28 years with the Danish pharma, including more than seven years as EVP ...

FDA faces major shakeup as CBER chief Peter Marks exits, Trump admin implements cuts across HHS, and new tariff plan creates industry confusion. Sens. Cassidy and Sanders seek answers.

Shanghai's RiboX Therapeutics begins first-ever circular RNA clinical trial, targeting dry mouth in cancer patients. Company ...

At least 2,000 of the 10,000 HHS employees let go this week will be reinstated because of “mistakes,” Robert F. Kennedy Jr.

Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate ...

Eli Lilly licenses Sangamo's BBB-penetrating AAV capsid for CNS disease with $18M upfront; deal includes option for 4 more ...

Singapore VC firm Vickers Venture Partners files for $180M IPO for second SPAC, Vickers Vantage Corp. II, following 2022 ...